Towards an advanced therapeutic medicinal product, autologous keratinocytes in solution for difficult-to-heal skin wounds

Objective: Keratinocytes-based therapy represents a potential solution for patients with difficult-to-heal skin wounds, which is considered as an advanced therapy medicinal product by the European Medicines Agency (EMA). We aimed at achieving a protocol for complete, EMA compliant, workflow.
Source: Journal of Plastic, Reconstructive and Aesthetic Surgery - Category: Cosmetic Surgery Authors: Source Type: research